Neurosarcoidosis: Guidance for the general neurologist;Neurosarcoidose: Orientações para o neurologista geral

Arquivos de Neuro-Psiquiatria

Volumn 70, Issue 4, 2012, Pages 293-299

  Dutra, Lívia Almeida ^a   Braga Neto, Pedro ^a   Oliveira, Ricardo Araújo ^a   Pedroso, José Luiz ^a   Abrahão, Agessandro ^a   Barsottini, Orlando Graziani Povoas ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Azathioprine; Cyclophosphamide; Infliximab; Methotrexate; Neurosarcoidosis; Sarcoidosis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE; ETANERCEPT; FOLIC ACID; GAMMA INTERFERON; GLUCOSE; HLA ANTIGEN; INFLIXIMAB; INTERLEUKIN 15; INTERLEUKIN 2; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TUMOR NECROSIS FACTOR ALPHA;

AMYLOIDOSIS; ARTICLE; BLOOD CELL COUNT; BONE MARROW APLASIA; BRAIN DISEASE; BRAIN MASS LESION; BRAIN WHITE MATTER LESION; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID; CHRONIC DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION LOSS; CRANIAL NEUROPATHY; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DRUG PULSE THERAPY; DYSLIPIDEMIA; FACIAL NERVE PARALYSIS; GENETIC LINKAGE; GLUCOSE INTOLERANCE; GRANULOMA; GUILLAIN BARRE SYNDROME; HALLUCINATION; HEADACHE; HEMORRHAGIC CYSTITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INTRACRANIAL PRESSURE; LABORATORY TEST; LEUKOENCEPHALOPATHY; LIVER FUNCTION; LUNG FUNCTION TEST; LUNG LAVAGE; MENINGITIS; MONONUCLEOSIS; MULTIPLE SCLEROSIS; MYCOSIS; MYOPATHY; NAUSEA; NEOPLASM; NEUROLOGIC DISEASE; NEUROLOGIST; NEUROPATHY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PLEOCYTOSIS; POLYMERASE CHAIN REACTION; POSTINFLUENZA; PROGNOSIS; PSYCHOSIS; RENAL SARCOIDOSIS; SARCOIDOSIS; SKIN SARCOIDOSIS; SPINAL CORD DISEASE; STEROID THERAPY; SYPHILIS; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT INDICATION; TUBERCULIN TEST; TUBERCULOSIS; UVEITIS; VIRUS REACTIVATION; VITAMIN SUPPLEMENTATION; WHOLE BODY PET;

EID: 84859841592     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2012000400014     Document Type: Article

References (49)

1. Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: a clinical dilemma. Lancet Neurol 2004;3:397-407.
2. Sharma OP, Shigemitsu H. A historical sketch: life and time of Jonathan Hutchinson (1828-1913), the first sarcoidologist. Sarcoidosis Vasc Diffuse Lung Dis 2008;25:71-75.
3. Vinas FC, Rengachary S. Diagnosis and management of neurosarcoidosis. J Clin Neurosci 2001;8:505-513.
4. Nowak DA, Widenka DC. Neurosarcoidosis: a review of its intracranial manifestation. J Neurol 2001;248:363-372.
5. Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997;157:1864-1868.
6. Whelan MA, Stern J. Sarcoidosis presenting as a posterior fossa mass. Surg Neurol 1981;15:455-457.
7. Tsao CY, Lo WD, Rusin JA, Henwood MJ, Boue DR. Isolated neurosarcoidosis presenting as headache and multiple brain and spinal cord lesions mimicking central nervous system metastases. Brain Dev 2007;29:514-518.
8. Sponsler JL, Werz MA, Maciunas R, Cohen M. Neurosarcoidosis presenting with simple partial seizures and solitary enhancing mass: case reports and review of the literature. Epilepsy Behav 2005;6:623-630.
9. Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) 1990;69:261-276.
10. Lawrence WP, el-Gammal T, Pool WH, Jr, Apter L. Radiological manifestations of neurosarcoidosis: report of three cases and review of literature. Clin Radiol 1974;25:343-348.
11. Oksanen V. Neurosarcoidosis: clinical presentations and course in 50 patients. Acta Neurol Scand 1986;73:283-290.
12. Byrne JV, Lawton CA. Meningeal sarcoidosis causing intracranial hypertension secondary to dural sinus thrombosis. Br J Radiol 1983;56:755-757.
13. Gilmore K, Rudden M, Kalman TP. Psychiatric manifestations of sarcoidosis. Can J Psychiatry 1980;25:329-331.
14. Scott TF. Neurosarcoidosis: progress and clinical aspects. Neurology 1993;43:8-12.
15. Zajicek JP, Scolding NJ, Foster O, et al. Central nervous system sarcoidosis-diagnosis and management. QJM 1999;92:103-117.
16. Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 1977;87:336-345.
17. Vital A, Lagueny A, Ferrer X, Louiset P, Canron MH, Vital C. Sarcoid neuropathy: clinico-pathological study of 4 new cases and review of the literature. Clin Neuropathol 2008;27:96-105.
18. Chen ES, Moller DR. Etiology of sarcoidosis. Clin Chest Med 2008;29:365-377.
19. Morgenthau AS, Iannuzzi MC. Recent advances in sarcoidosis. Chest 2011;139:174-182.
20. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004;170:1324-1330.
21. Gerke AK, Hunninghake G. The immunology of sarcoidosis. Clin Chest Med. 2008;29:379-390.
22. Stern BJ. Neurological complications of sarcoidosis. Curr Opin Neurol 2004;17:311-316.
23. Lynch JP 3rd. Neurosarcoidosis: how good are the diagnostic tests? J Neuroophthalmol 2003;23:187-189.
24. Bargagli E, Mazzi A, Rottoli P. Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas. Clin Chest Med. 2008;29:445-458.
25. Dubey N, Miletich RS, Wasay M, Mechtler LL, Bakshi R. Role of fluorodeoxyglucose positron emission tomography in the diagnosis of neurosarcoidosis. J Neurol Sci 2002;205:77-81.
26. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1995;171:857-863.
27. Donald PR, Victor TC, Jordaan AM, Schoeman JF, van Helden PD. Polymerase chain reaction in the diagnosis of tuberculous meningitis. Scand J Infect Dis 1993;25:613-617.
28. Nguyen LN, Kox LF, Pham LD, Kuijper S, Kolk AH. The potential contribution of the polymerase chain reaction to the diagnosis of tuberculosis meningitis. Arch Neurol 1996;53:771-776.
29. Smith JK, Matheus MG, Castillo M. Imaging manifestations of neurosarcoidosis. Am J Roentgenol 2004;182:289-295.
30. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol 1985;42:909-917.
31. Ranoux D, Devaux B, Lamy C, Mear JY, Roux FX, Mas JL. Meningeal sarcoidosis, pseudo-meningioma, and pachymeningitis of the convexity. J Neurol Neurosurg Psychiatry 1992;55:300-303.
32. Hoitsma E, Drent M, Sharma OP. A pragmatic approach to diagnosing and treating neurosarcoidosis in the 21st century. Curr Opin Pulm Med 2010;16:472-479.
33. Carmody RF, Mafee MF, Goodwin JA, Small K, Haery C. Orbital and optic pathway sarcoidosis: MR findings. AJNR Am J Neuroradiol 1994;15:775-783.
34. Ferriby D, de Seze J, Stojkovic T, et al. Long-term follow-up of neurosarcoidosis. Neurology 2001;57:927-929.
35. Chapelon-Abric C, Ziza JM, Piette JC, et al. Neurosarcoidosis. Ann Med Interne (Paris) 1991;142:601-608.
36. Lower EE, Weiss KL. Neurosarcoidosis. Clin Chest Med 2008;29:475-492.
37. Scott TF, Yandora K, Valeri A, Chieffe C, Schramke C. Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch Neurol 2000;64:691-696.
38. Agbogu BN, Stern BJ, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995;52:875-879.
39. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149-173.
40. Baughman RP, Costabel U, du Bois RM. Treatment of sarcoidosis. Clin Chest Med 2008;29:533-548.
41. Moravan M, Segal BM. Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology 2009;72:337-340.
42. Doty JD, Mazur JE, Judson MA. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest 2003;124:2023-2026.
43. Vargas DL, Stern BJ. Neurosarcoidosis: diagnosis and management. Semin Respir Crit Care Med 2010;31:419-427.
44. Santos E, Shaunak S, Renowden S, Scolding NJ. Treatment of refractory neurosarcoidosis with Infliximab. J Neurol Neurosurg Psychiatry 2010;81:241-246.
45. Pettersen JA, Zochodne DW, Bell RB, Martin L, Hill MD. Refractory neurosarcoidosis responding to infliximab. Neurology 2002;59:1660-1661.
46. Pereira J, Anderson NE, McAuley D, Bergin P, Kilfoyle D, Fink J. Medically refractory neurosarcoidosis treated with infliximab. Intern Med J 2011;41:354-357.
47. Doty JD, Mazur JE, Judson MA. Treatment of sarcoidosis with infliximab. Chest 2005;127:1064-1071.
48. Om P. Sharma. Neurosarcoidosis: A Personal Perspective Based on the Study of 37 Patients. Chest 1997;112:220-228.
49. Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM Med 2009;102:449-460.